<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02880878</url>
  </required_header>
  <id_info>
    <org_study_id>DC-6010</org_study_id>
    <nct_id>NCT02880878</nct_id>
  </id_info>
  <brief_title>ENRICH: Early MiNimally-invasive Removal of IntraCerebral Hemorrhage (ICH)</brief_title>
  <acronym>ENRICH</acronym>
  <official_title>ENRICH: A Multi-center, Randomized, Clinical Trial Comparing Standard Medical Management to Early Surgical Hematoma Evacuation Using Minimally Invasive Parafascicular Surgery (MIPS) in the Treatment of Intracerebral Hemorrhage (ICH).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nico Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nico Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicenter, randomized, adaptive clinical trial comparing standard medical
      management to early (&lt;24 hours) surgical hematoma evacuation using minimally invasive
      parafascicular surgery (MIPS) in the treatment of acute spontaneous supratentorial
      intracerebral hemorrhage.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ENRICH trial will compare the outcomes between early surgical intervention using the
      BrainPath® Approach (i.e., MIPS) and a medically managed cohort. The integrated surgical
      approach includes a combination of available technologies, including the FDA-cleared NICO
      BrainPath® for non-disruptive access and NICO Myriad® to achieve the goal of maximum clot
      evacuation. The medically managed cohort will be treated according the Clinical
      Standardization Guidelines (CSG) as adapted by Emory University from the 2015 AHA/ASA
      Guidelines for the Management of Spontaneous Intracerebral Hemorrhage. Clinical efficacy will
      be determined by demonstrating a 10% improvement in functional outcome, as determined by a
      blinded-assessment of the 180-day utility-weighted modified Rankin Scale (mRS).

      Data suggests improved mortality rates and potential functional benefits of surgical ICH
      evacuation. The methodology proposed for this trial was tested in a preliminary series of 39
      patients treated for supratentorial spontaneous ICH and retrospectively reviewed (Labib et
      al.). These results were replicated in a single center retrospective series of 18 patients
      (Bauer et al.). Despite positive results of both studies and the widely accepted benefit of
      the BrainPath Approach (i.e., MIPS) for subcortical lesions, stronger evidence supporting the
      use of these techniques in ICH is needed for the technique to become universally validated.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional Improvement - mRS</measure>
    <time_frame>180 days</time_frame>
    <description>Functional Improvement as determined by utility-weighted modified Rankin Scale (mRS) at 180-days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety - Procedure-Related Mortality</measure>
    <time_frame>30 days</time_frame>
    <description>Safety will be assessed by determining procedure-related mortality by comparing rates of mortality at 30 days for patients that underwent MIPS with medically treated patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety - Hemorrhage Volume</measure>
    <time_frame>24 hours</time_frame>
    <description>Safety will be assessed by evaluating whether MIPS does not result in an increase in hemorrhage volume between index CT and 24-hour follow-up CT as compared to medically treated patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Economic</measure>
    <time_frame>30, 90, 120, and 180 days</time_frame>
    <description>Economic differential as determined by quantification of the cost per quality-adjusted life-years (QALY) gained through MIPS</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Intracerebral Hemorrhage</condition>
  <condition>Cerebral Hemorrhage</condition>
  <condition>Intracerebral Haemorrhage</condition>
  <arm_group>
    <arm_group_label>Early Surgical Hematoma Evacuation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive early surgical hematoma evacuation using Minimally Invasive Parafascicular Surgery (MIPS).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medical Management</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects will receive standard of care medical management for ICH.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Early Surgical Hematoma Evacuation</intervention_name>
    <description>Early Minimally Invasive Parafascicular Surgery (MIPS)</description>
    <arm_group_label>Early Surgical Hematoma Evacuation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-80 years

          -  Pre-randomization head CT demonstrating an acute, spontaneous, primary ICH

          -  Manual ICH volume between 30 - 80 mL

          -  Study intervention can reasonably be initiated within 24 hours after the onset of
             stroke symptoms. If the actual time of onset is unclear, then the onset will be
             considered the time that the subject was last known to be well

          -  Glasgow Coma Score (GCS) 5 - 14

          -  Historical Modified Rankin Score 0 or 1

        Exclusion Criteria:

          -  Ruptured aneurysm, arteriovenous malformation (AVM), vascular anomaly, Moyamoya
             disease, venous sinus thrombosis, mass or tumor, hemorrhagic conversion of an ischemic
             infarct, recurrence of a recent (&lt;1 year) ICH, as diagnosed with radiographic imaging

          -  NIHSS &lt; 5

          -  Bilateral fixed dilated pupils

          -  Extensor motor posturing

          -  Intraventricular extension of the hemorrhage is visually estimated to involve &gt;50% of
             either of the lateral ventricles

          -  Primary Thalamic ICH

          -  Infratentorial intraparenchymal hemorrhage including midbrain, pontine, or cerebellar

          -  Use of anticoagulants that cannot be rapidly reversed

          -  Evidence of active bleeding involving a retroperitoneal, gastrointestinal,
             genitourinary, or respiratory tract site

          -  Uncorrected coagulopathy or known clotting disorder

          -  Platelet count &lt; 75,000, International Normalized Ratio (INR) &gt; 1.4 after correction

          -  Patients requiring long-term anti-coagulation that needs to be initiated &lt; 5 days from
             index ICH

          -  End stage renal disease

          -  Patients with a mechanical heart valve

          -  End-stage liver disease

          -  History of drug or alcohol use or dependence that, in the opinion of the site
             investigator, would interfere with adherence to study requirements

          -  Positive urine or serum pregnancy test in female subjects without documented history
             of surgical sterilization or is post-menopausal

          -  Known life-expectancy of less than 6 months

          -  No reasonable expectation of recovery, Do-Not-Resuscitate (DNR), or comfort measures
             only prior to randomization

          -  Participation in a concurrent interventional medical investigation or clinical trial.

          -  Inability or unwillingness of subject or legal guardian/representative to give written
             informed consent

          -  Homelessness or inability to meet follow up requirements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gustavo Pradilla, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>1-877-572-5511 | gpradil@emory.edu | Emory University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Penny Sekerak, MBA, BA, RN</last_name>
    <phone>317-660-7118</phone>
    <phone_ext>110</phone_ext>
    <email>Penny.Sekerak@niconeuro.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sean Spence</last_name>
    <phone>317-660-7118</phone>
    <phone_ext>115</phone_ext>
    <email>Sean.Spence@niconeuro.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Southern California (USC)</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anush Arakelyan, MPH, CCRP</last_name>
      <phone>323-442-7544</phone>
      <email>Anush.Arakelyan@med.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Gabriel Zada, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vicki Manoukian, MA</last_name>
      <phone>310-423-5067</phone>
      <email>vicki.manoukian@cshs.org</email>
    </contact>
    <investigator>
      <last_name>Michael Alexander, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami / Jackson Memorial Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lutecia Pereira</last_name>
      <phone>305-585-2099</phone>
      <email>lpereira@med.miami.edu</email>
    </contact>
    <contact_backup>
      <phone>305-243-2361</phone>
      <email>b.boyer@med.miami.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Eric Peterson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University School of Medicine - Primary Site &amp; Scientific Leadership Team</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gustavo Pradilla, MD</last_name>
      <phone>877-572-5511</phone>
      <email>ENRICH@emory.edu</email>
    </contact>
    <contact_backup>
      <last_name>Alex Hall, MS, RN</last_name>
      <phone>1-877-572-5511</phone>
      <email>ENRICH@emory.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Gustavo Pradilla, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jonathan Ratcliff, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Barrow, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Victoria Phillips, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Frankel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Wright, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jason Allen, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bart Jacher</last_name>
      <phone>312-942-1114</phone>
      <email>bartosz_jacher@rush.edu</email>
    </contact>
    <investigator>
      <last_name>Richard Webster Crowley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NorthShore University Health System</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boris Jancan, MD, CCRP</last_name>
      <phone>847-570-4224</phone>
      <email>bjancan@northshore.org</email>
    </contact>
    <contact_backup>
      <last_name>Robert Frech, BS, CCRP</last_name>
      <phone>847-570-4224</phone>
      <email>rfrech@northshore.org</email>
    </contact_backup>
    <investigator>
      <last_name>Shakeel Chowdhry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>OSF Saint Francis Medical Center</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Beck</last_name>
      <phone>309-624-3240</phone>
      <email>judith.m.beck@osfhealthcare.org</email>
    </contact>
    <contact_backup>
      <last_name>Kimberly Hartwig</last_name>
      <phone>309-655-4229</phone>
      <email>kimberly.hartwig@osfhealthcare.org</email>
    </contact_backup>
    <investigator>
      <last_name>Andrew Tsung, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauren Snyder, RN</last_name>
      <phone>317-396-1254</phone>
      <email>lmillar@iu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Heather Cero, RN</last_name>
      <phone>317-396-1298</phone>
      <email>hcero@iupui.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Mitesh Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Helie</last_name>
      <phone>410-955-5998</phone>
      <email>nhelie1@jhmi.edu</email>
    </contact>
    <investigator>
      <last_name>Gary Gallia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Taylor Krozy</last_name>
      <phone>617-732-8527</phone>
      <email>tkrozy@bwh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>M. Ali Aziz-Sultan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Louis University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virginia Wamser</last_name>
      <phone>314-977-4751</phone>
      <email>virginia.wamser@health.slu.edu</email>
    </contact>
    <investigator>
      <last_name>Jeroen Coppens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University (Barnes Jewish)</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Evans, RN, CCRC</last_name>
      <phone>314-362-3473</phone>
      <email>evansj@wudosis.wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Chicoine, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Albany Medical Center</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Graca, LPN</last_name>
      <phone>518-262-5868</phone>
      <email>gracal@mail.amc.edu</email>
    </contact>
    <investigator>
      <last_name>Alan Boulos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of North Carolina at Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Beckwith, BS, CCRP</last_name>
      <phone>919-843-8797</phone>
      <email>beckwitha@neurology.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Deanna Sasaki-Adams, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vikram Puvenna</last_name>
      <phone>216-444-3120</phone>
      <email>puvennv@ccf.org</email>
    </contact>
    <contact_backup>
      <last_name>Mark Bain, MD</last_name>
      <phone>216-445-6575</phone>
      <email>bainm@ccf.org</email>
    </contact_backup>
    <investigator>
      <last_name>Mark Bain, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Blair Apple, BS</last_name>
      <phone>405-271-4658</phone>
      <email>Blair-Apple@ouhsc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Brittany Karfonta, BS</last_name>
      <phone>405-27104658</phone>
      <email>Brittany-Karfonta@ouhsc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Bradley Bohnstedt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97035</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Williams</last_name>
      <phone>503-494-9546</phone>
      <email>nsg_clinicalresearch@ohsu.edu</email>
    </contact>
    <investigator>
      <last_name>Aclan Dogan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Geisinger Health System</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17821</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chelsie Derr</last_name>
      <phone>570-214-2432</phone>
      <email>cmderr1@geisinger.edu</email>
    </contact>
    <investigator>
      <last_name>Clemens Schirmer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Penn State Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Hoffman, RN</last_name>
      <phone>717-531-0003</phone>
      <phone_ext>283063</phone_ext>
      <email>dhoffman1@pennstatehealth.psu.edu</email>
    </contact>
    <investigator>
      <last_name>Kevin Cockroft, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center (UPMC)</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Baxendell</last_name>
      <phone>412-605-3959</phone>
      <email>baxelx@upmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Patricia Feineigle</last_name>
      <phone>412-647-4992</phone>
      <email>feineiglepa3@upmc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Brian Jankowitz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.enrichtrial.com</url>
    <description>ENRICH Trial Website</description>
  </link>
  <reference>
    <citation>Labib MA, Shah M, Kassam AB, Young R, Zucker L, Maioriello A, Britz G, Agbi C, Day JD, Gallia G, Kerr R, Pradilla G, Rovin R, Kulwin C, Bailes J. The Safety and Feasibility of Image-Guided BrainPath-Mediated Transsulcul Hematoma Evacuation: A Multicenter Study. Neurosurgery. 2017 Apr 1;80(4):515-524. doi: 10.1227/NEU.0000000000001316.</citation>
    <PMID>27322807</PMID>
  </reference>
  <reference>
    <citation>Chen CJ, Caruso J, Starke RM, Ding D, Buell T, Crowley RW, Liu KC. Endoport-Assisted Microsurgical Treatment of a Ruptured Periventricular Aneurysm. Case Rep Neurol Med. 2016;2016:8654262. doi: 10.1155/2016/8654262. Epub 2016 Apr 19.</citation>
    <PMID>27195160</PMID>
  </reference>
  <reference>
    <citation>Amenta PS, Dumont AS, Medel R. Resection of a left posterolateral thalamic cavernoma with the Nico BrainPath sheath: case report, technical note, and review of the literature. Interdisciplinary Neurosurgery: Advanced Techniques and Case Management. 2016; 5:12-17.</citation>
  </reference>
  <reference>
    <citation>Bauer AM, Rasmussen PA, Bain MD. Initial Single-Center Technical Experience With the BrainPath System for Acute Intracerebral Hemorrhage Evacuation. Oper Neurosurg (Hagerstown). 2017 Feb 1;13(1):69-76. doi: 10.1227/NEU.0000000000001258.</citation>
    <PMID>28931255</PMID>
  </reference>
  <reference>
    <citation>Ziai W, Nyquist P, Hanley DF. Surgical Strategies for Spontaneous Intracerebral Hemorrhage. Semin Neurol. 2016 Jun;36(3):261-8. doi: 10.1055/s-0036-1582131. Epub 2016 May 23. Review.</citation>
    <PMID>27214701</PMID>
  </reference>
  <reference>
    <citation>Fiorella D, Arthur A, Bain M, Mocco J. Minimally Invasive Surgery for Intracerebral and Intraventricular Hemorrhage: Rationale, Review of Existing Data and Emerging Technologies. Stroke. 2016 May;47(5):1399-406. doi: 10.1161/STROKEAHA.115.011415. Epub 2016 Apr 5. Review. Erratum in: Stroke. 2016 May;47(5):e91.</citation>
    <PMID>27048700</PMID>
  </reference>
  <reference>
    <citation>Chen JW, Paff MR, Abrams-Alexandru D, Kaloostian SW. Decreasing the Cerebral Edema Associated with Traumatic Intracerebral Hemorrhages: Use of a Minimally Invasive Technique. Acta Neurochir Suppl. 2016;121:279-84. doi: 10.1007/978-3-319-18497-5_48.</citation>
    <PMID>26463961</PMID>
  </reference>
  <reference>
    <citation>Przybylowski CJ, Ding D, Starke RM, Webster Crowley R, Liu KC. Endoport-assisted surgery for the management of spontaneous intracerebral hemorrhage. J Clin Neurosci. 2015 Nov;22(11):1727-32. doi: 10.1016/j.jocn.2015.05.015. Epub 2015 Jul 31.</citation>
    <PMID>26238692</PMID>
  </reference>
  <reference>
    <citation>Ding D, Przybylowski CJ, Starke RM, Sterling Street R, Tyree AE, Webster Crowley R, Liu KC. A minimally invasive anterior skull base approach for evacuation of a basal ganglia hemorrhage. J Clin Neurosci. 2015 Nov;22(11):1816-9. doi: 10.1016/j.jocn.2015.03.052. Epub 2015 Jun 30.</citation>
    <PMID>26142050</PMID>
  </reference>
  <reference>
    <citation>Kassam AB, Labib MA, Bafaquh M, et al. Part II: an evaluation of an integrated systems approach using diffusion-weighted, image-guided, Exoscopic-assisted, transulcal radial corridors. Innovative Neurosurg. 2015; 3(1-2): 25-33.</citation>
  </reference>
  <reference>
    <citation>Kassam AB, Labib MA, Bafaquh M, et al. Part I: the challenge of functional preservation: an integrated systems approach using diffusion-weighted, image-guided, Exoscopic-assisted, transulcal radial corridors. Innovative Neurosurgy. 2015; 3(1-2): 5-23.</citation>
  </reference>
  <reference>
    <citation>Ritsma B, Kassam A, Dowlatshahi D, Nguyen T, Stotts G. Minimally Invasive Subcortical Parafascicular Transsulcal Access for Clot Evacuation (Mi SPACE) for Intracerebral Hemorrhage. Case Rep Neurol Med. 2014;2014:102307. doi: 10.1155/2014/102307. Epub 2014 Aug 6.</citation>
    <PMID>25165588</PMID>
  </reference>
  <reference>
    <citation>Zucker, L. Corticospinal tract restoration post parafascicular transulcal subcortical (thalamic) ICH evacuation. Poster #1450 presented at: 2016 Congress of Neurological Surgeons Annual Meeting; September 24-28, 2016; San Diego, CA.</citation>
  </reference>
  <reference>
    <citation>Chen J, Tran K, Dastur C, Stradling D, Yu W. The use of the BrainPath stereotactic guided surgery for the removal of spontaneous intracerebral hemorrhage: a single institutional experience. Abstract presented at: 2015 NeuroCritical Care Society Meeting; October 7-10, 2015; Scottsdale, AZ.</citation>
  </reference>
  <reference>
    <citation>Kulwin C, Rodgers R, Shah M. Preliminary experience with evacuation of intracerebral hemorrhage via a minimally invasive parafascicular technique. Presented at: 2015 Neurosurgical Society of America Annual Meeting; April 2015.</citation>
  </reference>
  <reference>
    <citation>Chen J, Kaloostian SW. Use of minimally invasive techniques under austere circumstances for the urgent resection of subcortical intracerebral hemorrhages. Poster #0075 presented at: 12th Annual Conference of the Society for Brain Mapping and Therapeutics; March 6-8, 2015.</citation>
  </reference>
  <reference>
    <citation>Britz G, Kassam AB, Labib M, Young R, Zucker L, Maioriello A, et al. Minimally invasive subcortical parafascicular access for clot evacuation: a paradigm shift. Poster # MP120 presented at: 2015 International Stroke Conference; February 11-13, 2015; Nashville, TN.</citation>
  </reference>
  <reference>
    <citation>Labib M, Britz G, Young R, Zucker L, Shah M, Kulwin CG, et al. The safety and efficacy of image-guided trans-sulcal radial corridors for hematoma evacuation: a multicenter study. Late breaking oral presentation LB12 at: 2015 International Stroke Conference; February 11-13, 2015; Nashville, TN.</citation>
  </reference>
  <reference>
    <citation>Kulwin CG, Shah MV. Minimally invasive parafascicular approach to deep cerebral lesions: initial Indiana University experience. Presented at: 2014 Neurosurgical Society of America Annual Meeting; June 2014.</citation>
  </reference>
  <reference>
    <citation>Labib M, Ghinda D, Bafaquh M, Kumar R, Agbi C, Kassam AB. The diffusion tensor imaging (DTI) guided Transulcul Exoscopic radial corridor approach for the resection of lesions in the sensorimotor area. Poster #1598 presented at: 2013 Congress of Neurological Surgeons Annual Meeting; October 19-23, 2013; San Francisco, CA.</citation>
  </reference>
  <reference>
    <citation>Ghinda DC, Bafaquh M, Labib M, Kumar R, Agbi CB, Kassam AB. A Transulcul Exoscopic radial corridor approach for the management of primary intracranial hemorrhage. Poster #1621 presented at: 2013 Congress of Neurological Surgeons Annual Meeting; October 19-23, 2013; San Francisco, CA.</citation>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 18, 2016</study_first_submitted>
  <study_first_submitted_qc>August 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2016</study_first_posted>
  <last_update_submitted>November 16, 2017</last_update_submitted>
  <last_update_submitted_qc>November 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Subcortical Intracerebral Hemorrhage</keyword>
  <keyword>Intracerebral Hemorrhage</keyword>
  <keyword>Intracranial Hemorrhages</keyword>
  <keyword>ICH</keyword>
  <keyword>Hemorrhage</keyword>
  <keyword>Cerebrovascular Disorders</keyword>
  <keyword>Brain Diseases</keyword>
  <keyword>Central Nervous System Diseases</keyword>
  <keyword>Nervous System Diseases</keyword>
  <keyword>Vascular Diseases</keyword>
  <keyword>Cardiovascular Diseases</keyword>
  <keyword>Pathologic Processes</keyword>
  <keyword>MIPS</keyword>
  <keyword>Minimally Invasive Parafascicular Surgery</keyword>
  <keyword>Neurosurgery</keyword>
  <keyword>Medical Economic</keyword>
  <keyword>Hospital Economics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Cerebral Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

